San Francisco, California 18-MAY-2025 — Perspective Pharmacovigilance, Inc (PPV), a leading provider of strategic pharmacovigilance services, is pleased to announce the appointment of Kieran O’Donnell as Managing Director and EU Practice Lead, reinforcing the company’s commitment to delivering fit-for-purpose pharmacovigilance & benefit-risk solutions across Europe and the UK.

Kieran brings over 25 years of experience in the pharmaceutical, CRO, and consulting sectors, with deep expertise in:

·      Pharmacovigilance system design and implementation

·      Global regulatory compliance frameworks

·      Benefit-risk assessment strategy

·      Risk Management Plans (RMPs), signal detection, periodic safety reporting and labeling

·      EU Qualified Person for Pharmacovigilance (QPPV)responsibilities

In his new role, Kieran will lead and expand PPV’s EU Practice and collaborate with PPV’s existing EU-based consulting team to deliver tailored pharmacovigilance solutions that address the evolving needs of clients engaged in global clinical development and commercial launch. His leadership will play a key role in aligning regional operations with global strategies—ensuring clients receive proactive, benefit-risk-centered support in line with evolving EMA and MHRA expectations.

“Kieran’s appointment marks a pivotal moment for Perspective PV,” said Bethany Van Veen, CEO and Founder. “His expertise in PV system design and proactive risk management will help our clients navigate complex EU regulatory frameworks with confidence, while strengthening Perspective PV’s ability to deliver practical, high-quality solutions for evolving pharmacovigilance needs.”

Kieran added:

“I’m honored to join Perspective PV at this exciting stage of its growth. Together, we’ll empower clients to stay ahead in an increasingly complex regulatory landscape—combining expert insight, operational excellence, and a deep commitment to patient safety.”

Let’s connect! Message info@perspectivepv.com to explore how Perspective PV can support your pharmacovigilance needs across Europe and the UK.

‍